¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¾¾ç³»°úÇÐȸ Liver Cancer Symposium 2023 : 2023-11-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÁ¾¾ç³»°úÇÐȸ Liver Cancer Symposium 2023 : 2023-11-11
±³À°ÀÏÀÚ : 2023-11-11
±³À°Àå¼Ò : ÀÎÅÍÄÁƼ³ÙÅ» ÄÚ¿¢½º ´ÙÀ̾ƸóµåȦ

±³À°ÁÖÁ¦ : Liver Cancer Symposium 2023

ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ±è¿¹Áö
¿¬¶ôó : 02-735-2857  

À̸ÞÀÏ : meetings@ksmo.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 25ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í "Á¤È¸¿ø 30000¿ø / ÁØȸ¿ø 10000¿ø 

ºñȸ¿ø 50000¿ø"  


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 09:00~09:05 Opening À̸í¾Æ(¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 09:05~09:30 Pemigatinib-related translational research, translational learnings regarding the treatment of cancers with FGFR alterations Aidan Gilmartin(Incyte Corporation)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 09:30~09:50 The Role of Radiation Therapy for intrahepatic lesions ¹ÚÈñö(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 09:50~10:10 TARE vs TACE ±è°Ç¿µ(ºÐ´ç¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 10:10~10:30 Expanding the Role of Surgical Resection and Transplantation in Intermediate-Stage HCC ÀÌÇØ¿ø(ºÐ´ç¼­¿ï´ëÇб³º´¿ø)

Åä·Ð 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 10:30~10:50 Case Discussion õÀç°æ(¾Æ»êº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 11:00~11:20 Adjuvant Therapy in HCC? ±èÈ«½Ä(ÃæºÏ´ëÇб³)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 11:20~11:40 Systemic Therapy in Intermediate-Stage HCC: A Paradigm Shift? ±èÅ¿ë(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 11:40~12:00 Optimal First-Line Therapy for HCC ±èÁÖ¿ø(°í·Á´ëÇб³¾È¾Ïº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 12:00~12:20 Potential Biomarkers for immunotherapy ÀüÈ«Àç(ºÐ´çÂ÷º´¿ø)

Åä·Ð 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 12:20~12:30 Discussion ( )

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 12:30~13:30 Optimal treatment selection for 1L uHCC patients ; Focused on the potential candidates for TKIs? È«Á¤¿ë(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 13:30~13:50 Pathological and Molecular Features of Intrahepatic Cholangiocarcinoma ±èÇý·É(¼­¿ï´ëÇб³º´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 13:50~14:10 Surgical Management of Intrahepatic Cholangiocarcinoma: A Comparison with HCC ÇÑ´ëÈÆ(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 14:10~14:30 Systemic Therapy for Intrahepatic Cholangiocarcinoma: Current and Future Perspectives ÃÖÇýÁø(¼¼ºê¶õ½ºº´¿ø)

Åä·Ð 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 14:30~14:40 Discussion ( )

±âŸ 11¿ù 11ÀÏ ´ÙÀ̾ƸóµåȦ 14:40~14:45 Closing ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¾¾ç³»°úÇÐȸ Liver Cancer Symposium 2023 : 2023-11-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦12ȸ ´ëÇÑÀ忬±¸ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ ¿¬¼ö°­Á : 2023-11-11
´ÙÀ½±Û PRS KOREA 2023 ´ëÇѼºÇü¿Ü°úÇÐȸ Á¦81Â÷ ±¹Á¦Çмú´ëȸ(1ÀÏÂ÷) : 2023-11-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21135 °æ±â Á¦10Â÷ ¿¬¼¼ÀÇ´ë ¼Ò¾Æû¼Ò³â°ú Áö¿ªÀÇ»ç Áý´ãȸ : 2024-07-31 0 13 2024-06-19
21134 °æ±â 2024 Çѱ¹¼ö¸éÇÐȸ ÇÏ°èÇмú´ëȸ : 2024-07-26 0 29 2024-06-19
21133 ¼­¿ï 2024³â ´ëÇÑÇǺη¹ÀÌÀúÇÐȸ Á¦25ȸ Çмú´ëȸ : 2024-07-21 0 20 2024-06-19
21132 ¼­¿ï ´ëÇÑÀÓ»ó¾Ï´ë»çÀÇÇÐȸ 2024³â Ãß°èÇмú´ëȸ IVC¿Í Detox : 2024-07-21 0 11 2024-06-19
21131 ´ë±¸ ´ë±¸°æºÏ³»°úÇÐȸ 2024³â Á¤±âÇмú´ëȸ : 2024-07-21 0 11 2024-06-19
21130 Á¦ÁÖ Á¦13ȸ ´ëÇѳ»ºÐºñÇÐȸ Á¦ÁÖÁöȸ ¿¬¼ö°­Á : 2024-07-20 0 7 2024-06-19
21129 ±¤ÁÖ Á¦225Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ ±¤ÁÖÀü³²Áöȸ ¿¬¼ö°­Á : 2024-07-16 0 11 2024-06-19
21128 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦3ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-07-15 0 13 2024-06-19
21127 ¼­¿ï 2024 ¼¼ºê¶õ½ºº´¿ø ¼ÒÈ­±âÇÐ ¿¬¼ö°­Á : 2024-07-14 0 12 2024-06-19
21126 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑôÃß¿µ»óÀÇÇÐȸ Á¤±â¿¬¼ö°­Á : 2024-07-14 0 7 2024-06-19
21125 ¼­¿ï Á¦29Â÷ Ưº°¿¬¼ö°­Á – »êºÎÀΰú Áúȯ óġÀÇ ÃֽŠÁö°ß : 2024-07-14 0 14 2024-06-19
21124 °­¿ø 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ ¿¬¼ö°­Á : 2024-07-14 0 9 2024-06-19
21123 ¼­¿ï 2024³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãá°è ¹Ì¼¼¼ö¼ú ¿öÅ©¼ó : 2024-07-14 0 13 2024-06-19
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 7 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 10 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷